Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve unaudited financial results ....
FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fermenta Biotech Ltd has informed BSE that its Board of Directors will meet on November 11, 2025 to consider and approve the unaudited financial results (both standalone and consolidated) for the quarter and half year ended September 30, 2025. The filing is made under SEBI's Listing Regulations (Reg. 29), which mandates advance intimation of board meetings that take up financial results. The company's trading window for insiders, directors, promoters and designated persons has been closed since October 1, 2025 and will remain closed until 48 hours after the results are declared. The letter is signed by the Company Secretary & Head - Legal. No actual financial numbers, guidance or other agenda items are disclosed in this filing.
This is a routine regulatory disclosure ahead of the Q2/H1 FY26 earnings announcement on November 11, 2025. Investors should watch the actual results for revenue, profitability and margin trends, but no immediate price-moving signal can be inferred from this notice alone.